ii) Inducing systemic anti-tumor immunity11: The immune system receives immune “danger” signals after OVs infect tumor cells, and then activates multiple signal transduction pathways, including nuclear factor kappa-B (NF-κB), interferon regulatory factor (IRF), and mitogen-activated protein kinase (MAPK) pathways. The gene discussed is NFKB1; the disease is neoplasm.